Wedbush Upgrades Cross Country Healthcare to Outperform, Raises Price Target to $15

Wedbush analyst Michael Piccolo has upgraded Cross Country Healthcare (NASDAQ: CCRN) from Neutral to Outperform. The price target for the stock has been raised from $11 to $15.